SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-054169
Filing Date
2021-08-31
Accepted
2021-08-31 20:00:14
Documents
2
Period of Report
2021-08-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 8131
2 POA DOCUMENT poa.txt EX-24.4_1006551 3766
  Complete submission text file 0001209191-21-054169.txt   13250
Mailing Address 139 MAIN STREET CAMBRIDGE MA 02142
Business Address 139 MAIN STREET CAMBRIDGE MA 02142 857-204-4583
iTeos Therapeutics, Inc. (Issuer) CIK: 0001808865 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ITEOS THERAPEUTICS, INC. 139 MAIN STREET CAMBRIDGE MA 02142
Business Address
Detheux Michel (Reporting) CIK: 0001816196 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39401 | Film No.: 211228416